111 related articles for article (PubMed ID: 4149699)
1. Symposium on allergic lung disease. V. Selective drug treatments for bronchial asthma.
Jack D
Can Med Assoc J; 1974 Feb; 110(4):436 passim. PubMed ID: 4149699
[TBL] [Abstract][Full Text] [Related]
2. The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol.
Giles RE; Williams JC; Finkel MP
J Pharmacol Exp Ther; 1973 Sep; 186(3):472-81. PubMed ID: 4147005
[No Abstract] [Full Text] [Related]
3. [Bronchodilating effect of Berotec in bronchial asthma].
Adamek T; Czerniawska-Mysik G; Szczeklik A
Pol Tyg Lek; 1974 Jan; 29(3):111-2. PubMed ID: 4594955
[No Abstract] [Full Text] [Related]
4. Metaproterenol, a potent and safe bronchodilator.
Hurst A
Ann Allergy; 1973 Oct; 31(10):460-6. PubMed ID: 4148976
[No Abstract] [Full Text] [Related]
5. [Beta 2-adrenomimetric substances dilating the lumen of airway passages. Review].
Smejkal V
Vnitr Lek; 1972 Nov; 18(11):1117-24. PubMed ID: 4404499
[No Abstract] [Full Text] [Related]
6. [Cumulative dosage study on the effect of NAB 365 and fenoterol on the values of pulmonary function, blood pressure, pulse rate and general tolerance].
Uhl O
Arzneimittelforschung; 1974 Jun; 24(6):855-8. PubMed ID: 4152655
[No Abstract] [Full Text] [Related]
7. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
Van Der Straeten M; Lamont H; Pauwels R; Tasson J
Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
[No Abstract] [Full Text] [Related]
8. Newer therapeutic agents for asthma.
Deykin A; Israel E
Adv Intern Med; 1999; 44():209-37. PubMed ID: 9929710
[TBL] [Abstract][Full Text] [Related]
9. [The MMW Drug Prize 2002: Prize for a new classic with innovation potential].
Schultze-Werninghaus G
Med Klin (Munich); 2002 Dec; 97 Suppl 2():1. PubMed ID: 12593173
[No Abstract] [Full Text] [Related]
10. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
Verstraeten JM
Acta Tuberc Pneumol Belg; 1976; 67(3-4):130-55. PubMed ID: 138352
[No Abstract] [Full Text] [Related]
11. Use of 'Fixed' combination preparations of inhaled short acting b-2 agonists and inhaled corticosteroids.
Gupta A
Indian Pediatr; 2000 Jul; 37(7):752-4. PubMed ID: 10906807
[No Abstract] [Full Text] [Related]
12. [Efficacy of salmeterol in patients with allergic bronchial asthma].
Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
[TBL] [Abstract][Full Text] [Related]
13. Controlling asthma. Highlights of the 1999 Canadian Asthma Consensus Report.
D'Urzo AD
Can Fam Physician; 2000 Apr; 46():895-8, 902-4. PubMed ID: 10790822
[No Abstract] [Full Text] [Related]
14. [Comparative evaluation of the bronchodilator effects and cardiovascular effects of 3 beta adrenergic stimulants in bronchial asthma--comparison of isoproterenol, metaproterenol and salbutamol].
Matsumoto S; Tanaka Y; Wagatsuma Y; Miura R; Umezu A
Arerugi; 1971 Aug; 20(8):599-609. PubMed ID: 4398383
[No Abstract] [Full Text] [Related]
15. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
Dano P; Falholt W
Ugeskr Laeger; 1971 Apr; 133(15):685-8. PubMed ID: 4396922
[No Abstract] [Full Text] [Related]
16. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
Kokubu H
Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
[TBL] [Abstract][Full Text] [Related]
17. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
[No Abstract] [Full Text] [Related]
18. Drugs for asthma.
Med Lett Drugs Ther; 1995 Jan; 37(939):1-4. PubMed ID: 7799844
[No Abstract] [Full Text] [Related]
19. Pharmacological management of asthma.
McDonald C; Lipp J
Aust Fam Physician; 1998; 27(1-2):64-8, 70. PubMed ID: 9503709
[TBL] [Abstract][Full Text] [Related]
20. [Bronchial asthma: factors which contribute to "intractable asthma" and approach to new treatments, from the standpoint of the bronchial pathophysiology].
Satake T
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Sep; 23(9):971-80. PubMed ID: 2869175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
